NeuRA Magazine #20

CHILDHOOD TRAUMA AND PSYCHOSIS

Understanding the various causes of psychosis is a key way to improve treatments. Dr Yann Quidé is using fMRI to understand how childhood trauma may change the brain of a person who has experienced psychosis.

Dr Yann Quidé

There is increasing evidence that exposure to childhood trauma is a risk factor for some psychiatric conditions, including post-traumatic stress disorder, depression, anxiety and psychotic disorders. Trauma may present a different pathway to illness compared to those who have a psychiatric condition but who did not experience childhood trauma, and so may require a different treatment approach.

Within the Imaging Genetics in Psychosis project, lead by Assoc Prof Melissa Green, around 60 percent of psychosis patients and around 40 percent of healthy participants were exposed to significant levels of childhood trauma. This includes emotional and physical abuse, neglect and sexual abuse. Interestingly, there is a significant overlap between the cognitive domains that are usually affected in psychotic disorders, and those reported in (non-psychotic) psychiatric and non-psychiatric populations exposed to childhood trauma. The overlap appears to include executive functions, working memory and social cognition.

To identify these trauma-related brain abnormalities in psychosis, participants underwent functional magnetic resonance imaging (fMRI) while performing tasks that use the previously mentioned overlapping cognitive domains. Results indicated that being exposed to trauma was associated with inefficient activation of key brain regions for working memory in psychosis patients.

The study, led by Dr Yann Quidé, also found that some people with schizophrenia or schizoaffective disorder who experienced childhood trauma present abnormal patterns of brain function in regions important to understanding another person’s mental state, also called theory-of-mind. These findings confirm that trauma-exposure leads to distinct brain abnormalities in psychosis, and may help to improve personalised approaches to treatment of psychosis.

However, childhood trauma exposure also sets off a cascade of other biological processes that influence the pathway to illness. These include the stress system, otherwise known as the HPA (hypothalamic pituitary adrenal) axis; pro-inflammatory immune responses; or neuronal growth and differentiation. Modifications of these biological markers can lead to the physiological changes in brain structure or function, as we observed.

Dr Yann Quidé recently received an 2016 Early-Career Project Grant award from the Society for Mental Health Research (SMHR) in order to further investigate the associations between these biological dysfunctions, trauma-exposure and psychosis.

See what’s going on at NeuRA

FEEL THE BUZZ IN THE AIR? US TOO.

'I've got the best job for you dad. Your shaky arm will be perfect for it!'

Children… honest and insightful. Their innocence warms the heart. But what words do you use to explain to a child that daddy has an incurable brain disease? What words tell them that in time he may not be able to play football in the park, let alone feed himself? What words help them understand that in the later stages, dementia may also strike? Aged just 36, this was the reality that faced Steve Hartley. Parkinson's disease didn't care he was a fit, healthy, a young dad and devoted husband. It also didn't seem to care his family had no history of it. The key to defeating Parkinson's disease is early intervention, and thanks to a global research team, led by NeuRA, we're pleased to announce that early intervention may be possible. Your support, alongside national and international foundations Shake it Up Australia and the Michael J Fox Foundation, researchers have discovered that a special protein, found in people with a family history of the disease increases prior to Parkinson’s symptoms developing. This is an incredible step forward, because it means that drug therapies, aimed at blocking the increase in the protein, can be administered much earlier – even before symptoms strike. The next step is to understand when to give the drug therapies and which people will most benefit from it. But we need your help. A gift today will support vital research and in time help medical professionals around the world treat Parkinson’s disease sooner, with much better health outcomes. Thank you, in advance, for your support.  
APPEAL